Vaxxas

[On Demand]
Search General Info
Search Education
Search Partnering Companies
The needle-free future of vaccination
An advanced platform that vaccinates by applying a patch to the skin for a few seconds. Engineered to directly deposit vaccine amongst dense population of key immune cells in the skin, developing an efficient and effective immune response.
Company Type:
Privately Funded Company
Company Website:
Company HQ State:
Massachusetts
Company HQ Country:
United States
Year Founded:
2009
Main Therapeutic Focus:
Lead Product in Development:
Nanopatch
Development Phase of Primary Product:
Number Of Unlicensed Products (For Which You Are Seeking Partners):
Not Provided
Speaker
photo
Advance Qld Industry Research Fellow
University of Queensland / Vaxxas